Delivery Order SPE2DB22D1017-SPE2DB24FE9WR
- Not listed
- This federal contract award, with ID SPE2DB20D6035|SPE2DB25FLXWT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 40 mg capsules, with a ceiling value of $1,225.17 and a performance period through April 18, 2025. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a larger Indefinite...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ43D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carvedilol ER 40 mg capsules and has a ceiling value of $2,986.77. It is a firm fixed-price delivery order contract with a completion date of December 9, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, valued at $2,380.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 MG capsules, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $6,333.66 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the company's broader Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,481.50 delivery order contract is for the supply of Carvedilol ER 40 mg capsules to support federal healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a medication used to treat certain heart conditions. The award is a Delivery Order with a Firm Fixed Price of $1,331.63 and an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug...
- This federal contract award, valued at $2,464.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract is a firm fixed-price delivery order with a completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,285.52, is for the delivery of Carvedilol ER 40 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,391.55, is for the delivery of Carvedilol ER 40 mg capsules. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, in quantities of 30 per package. The contract has a ceiling value of $3,896.17 and an ultimate completion date of November 17, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE9WRDelivery Order
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE9WR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carvedilol ER 40 mg capsules in 30-count packages, with a total ceiling value of $1,027.79 and an ultimate completion date of December 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/14/23 |